Prescription drug · NDA
Mesnex (Mesna) NDC 67108-3565
Mesna 400 mg/1 · Tablet, Film coated · Oral · Baxter Healthcare Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67108-3565-9 | 67108356509 | 10 BLISTER PACK in 1 CARTON (67108-3565-9) / 1 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Mar 21, 2002 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mesnex
- Generic name (nonproprietary)
- mesna
- Active ingredients
- Mesna — 400 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Baxter Healthcare CompanyNDC labeler code 67108
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020855
- Marketing start
- Listing expires
- Identifiers
- Product ID 67108-3565_faac31b9-1006-4763-9443-74def34f1c38SPL ID faac31b9-1006-4763-9443-74def34f1c38SPL set ID 4a51ffdb-f59f-4e02-b3c4-f3457ab7b514RxCUI 142113, 352210UNII NR7O1405Q9
- Pharmacologic class
- Cytoprotective Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467108356509followed by a unit qualifier and the quantityPackage 67108-3565-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
MESNEX is indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Limitation of Use: MESNEX is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. MESNEX is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. ( 1 ) Limitation of Use: MESNEX is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 67108-3565
- What is NDC 67108-3565?
- 67108-3565 is the product NDC for Mesnex (mesna), Mesna 400 mg/1 tablet, film coated, listed with the FDA by Baxter Healthcare Company. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Mesnex (Mesna).
- What is the active ingredient?
- Mesna.
- Who is the labeler?
- Baxter Healthcare Company, NDC labeler code 67108. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Mesnex?
- 3 other product NDCs are listed under this name. See all Mesnex NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Mesnex products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Mesnexmesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 0338-1305 | 00338-1305-0100338-1305-03 |
| Mesnexmesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Company | 0338-1307 | 00338-1307-05 |
| Mesnexmesna | Mesna 100 mg/mL | Injection, SolutionIntravenous | Bamboo US Bidco LCC | 83703-559 | 83703-0559-0183703-0559-03 |